| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |